Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial - Enebo, LB; Berthelsen, KK; Kankam, M (Lancet (London, England), 2021)
et al.